You are here: Industry Insights > cancer

News List

Puma licences breast cancer therapy to Pierre Fabre in Europe pharmaceutical-technology
April 23, 2019
Puma licences breast cancer therapy to Pierre Fabre in Europe.
AstraZeneca’s Lynparza gets EC approval for breast cancer pharmaceutical-technology
April 23, 2019
The European Commission (EC) has approved AstraZeneca drug Lynparza (olaparib) as a monotherapy to treat locally-advanced or metastatic breast cancer in adults.
Repurposing cancer drugs may lead to a new approach to treating TB europeanpharmaceuticalreview
April 22, 2019
Promising experimental cancer chemotherapy drugs may help knock out another life-threatening disease: tuberculosis (TB)…
Moleculin Announces Significant Discovery in Lung Cancer Models americanpharmaceuticalreview
April 22, 2019
Moleculin Announces Significant Discovery in Lung Cancer Models...
Janssen’s bladder cancer drug Balversa receives FDA nod pharmaceutical-technology
April 22, 2019
Janssen Pharmaceutical has received the US Food and Drug Administration (FDA) approval for the drug Balversa (erdafitinib) to treat adults with locally advanced or metastatic urothelial carcinoma (mUC).
Developing a new radioactive marker for cancer diagnosis and detection europeanpharmaceuticalreview
April 22, 2019
Scientists are conducting a joint study to develop a radioactive marker, based on nanoparticles, for the detection of cancer…
Saliva diagnostics: Will saliva translate into a real diagnostic tool? europeanpharmaceuticalreview
April 22, 2019
Saliva has been used to measure stress hormones, enzyme levels and cancer mutations…
Blood test can detect early stage pancreatic cancer europeanpharmaceuticalreview
April 22, 2019
A blood test has been developed to detect pancreatic cancer at its earliest stages with an accuracy rate of 96 percent…
Prostate cancer treatment reduced from 37 treatments to 5 europeanpharmaceuticalreview
April 22, 2019
A minimally invasive hydrogel technology was administered, and has previously shown to decrease treatment side effects…
Cardiac monitoring for high-risk breast cancer patients ‘should be prioritised’ europeanpharmaceuticalreview
April 19, 2019
Cardiac monitoring of high-risk breast cancer patients should be prioritised, after research revealed low rates of heart monitoring seen in the patients receiving trastuzumab.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 88 89 Next page